Latest News about Top Stories
Recent news which mentions Top Stories
FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients
March 31, 2025
From Benzinga
From Benzinga
CAVA Can Outgrow Expectations With Strong Unit Economics And Market Headroom, Analyst Says
March 31, 2025
From Benzinga
Stocks Fall, S&P 500 Eyes Worst Month In Almost Two Years, Oil Rallies: What's Driving Markets Monday?
March 31, 2025
From Benzinga
From Benzinga
From Benzinga
Rocket Fuels Mortgage Empire With $9.4 Billion Mr. Cooper Acquisition—One In Six US Mortgages Now Under Its Roof
March 31, 2025
From Benzinga
From Benzinga
Palatin Technologies' Obesity Drug Co-Administered With Eli Lilly's Blockbuster Drug Shows 4.4% Reduction In Weight
March 31, 2025
From Benzinga
From Benzinga
CoreWeave IPO Performance Likely Due To Company, Not AI Sector: Analyst Says 'Investor Sentiment Remains Mixed'
March 31, 2025
From Benzinga
EXCLUSIVE: Could Trump's 'Liberation Day' Reciprocal Tariffs Crash The Stock Market? 48% Say This
March 31, 2025
Tickers
SPY
From Benzinga
PDD Stock Eyes Golden Cross As Temu's Growth Battle Heats Up
March 31, 2025
From Benzinga
Rocket Acquires Mr. Cooper Just Weeks After Buying Redfin, 'Brings Together The Homeownership Experience At Scale'
March 31, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.